Early differential expression of oncostatin M in obstructive nephropathy

Journal of Interferon and Cytokine Research

Volumn 30, Issue 7, 2010, Pages 513-523

  Elbjeirami, Wafa M ^a   Truong, Luan D ^b   Tawil, Ahmad ^c   Wang, Wansheng ^d   Dawson, Sara ^c   Lan, Hui Y ^e   Zhang, Ping ^d   Garcia, Gabriela E ^d   Wayne Smith, C ^c  

^a KING HUSSEIN CANCER CENTER   (Jordan)

^b HOUSTON METHODIST HOSPITAL   (United States)

^c Children's Nutritional Research Center   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CXCL14 CHEMOKINE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 3; ONCOSTATIN M; ONCOSTATIN M RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL INFILTRATION; CONTROLLED STUDY; DISEASE COURSE; DNA MICROARRAY; FIBROBLAST; FIBROGENESIS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CELL; KIDNEY FIBROSIS; KIDNEY PARENCHYMA; KIDNEY TUBULE CELL; KIDNEY TUBULE EPITHELIUM; LEUKOCYTE; MALE; MICROARRAY ANALYSIS; MOUSE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; URETER OBSTRUCTION; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, BLOCKING; CELL TRANSDIFFERENTIATION; CELLS, CULTURED; CHEMOKINES; EPITHELIAL CELLS; FIBROSIS; GENE EXPRESSION PROFILING; HUMANS; KIDNEY TUBULES; MALE; MICE; MICE, INBRED C57BL; MYOFIBROBLASTS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOSTATIN M; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ONCOSTATIN M; URETERAL OBSTRUCTION;

MUS;

EID: 77954890325     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2009.0105     Document Type: Article

References (47)

1. Behrens J, Birchmeier W, Goodman SL, Imhof BA. 1985. Dissociation of Madin-Darby canine kidney epithelial cells by the mono-clonal antibody anti-arc-1: mechanistic aspects and identifica-tion of the antigen as a component related to uvomorulin. J Cell Biol 101(4):1307-1315.
2. Brown TJ, Lioubin MN, Marquardt H. 1987. Purification and char-acterization of cytostatic lymphokines produced by activated human T lymphocytes. Synergistic antiproliferative activ-ity of transforming growth factor beta 1, interferon-gamma, and oncostatin M for human melanoma cells. J Immunol 139(9):2977-2983.
3. Dauthville S, Fischer E, Mougenot B, Delauche M, Ronco P, Rossert J. 1998. Identification of type I collagen-producing cells during interstitial fibrosis induced by unilateral ureteral obstruction. J Am Soc Nephrol 9:514A.
4. De Longh RU, Wederll E, Lovicu FJ, McAvoy JW. 2005. Transforming growth factor-induced epithelial-mesenchymal transition in the lens: a model for cataract formation. Cells Tissues Organs 179:43-55.
5. Douglas AM, Grant SL, Goss GA, Clouston DR, Sutherland RL, Begley CG. 1998. Oncostatin M induces the differentiation of breast cancer cells. Int J Cancer 75(l):64-73.
6. Fan JM, Ng YY, Hill PA, Nikolic-Paterson DJ, Mu W, Atkins RC, Lan HY. 1999. Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int 56(4):1455-1467.
7. Feng L, Garcia GE, Yang Y, Xia Y, Gabbai FB, Peterson OW, Abraham JA, Blantz RC, Wilson CB. 2000. Heparin-binding EGF-like growth factor contributes to reduced glomerular fil-tration rate during glomerulonephritis in rats. J Clin Invest 105(3):341-350.
8. Fukuda K, Yoshitomi K, Yanagida T, Tokumoto M, Hirakata H. 2001. Quantification of TGF-beta1 mRNA along rat nephron in obstructive nephropathy. Am J Physiol Renal Physiol 281(3):F513-F521.
9. Gatsios P, Haubeck HD, Van de Leur E, Frisch W, Apte SS, Greiling H, Heinrich PC, Graeve L. 1996. Oncostatin M differentially regulates tissue inhibitors of metalloproteinases TIMP-1 and TIMP-3 gene expression in human synovial lining cells . Eur J Biochem 241(1):56-63.
10. Goren I, Kampfer H, Miiller E, Schiefelbein D, Pfeilschifter J, Frank S. 2006. Oncostatin M expression is functionally connected to neutrophils in the early inflammatory phase of skin repair: implications for normal and diabetes-impaired wounds. J Invest Dermatol 126(3):628-637.
11. Grenier A, Dehoux M, Boutten A, Arce-Vicioso M, Durand G, Gougerot-Pocidalo MA, Chollet-Martin S. 1999. Oncostatin M production and regulation by human polymorphonuclear neu- trophils. Blood 93(4):1413-1421.
12. Hasegawa M, Sato S, Ihn H, Takehara K. 1999. Enhanced production of interleukin-6 (IL-6), oncostatin M and soluble IL-6 receptor by cultured peripheral blood mononuclear cells from patients with systemic sclerosis. Rheumatology (Oxford) 38(7):612-617.
13. Hay ED, Zuk A. 1995. Transformations between epithelium and mesenchyme: normal, pathological, and experimentally induced. Am J Kidney Dis 26(4):678-690.
14. Healy E, Leonard M, Madrigal-Estebas L, O'Farrelly C, Watson AJ, Ryan MP. 1999. Factors produced by activated leuko-cytes alter renal epithelial cell differentiation. Kidney Int 56(4):1266-1269.
15. Jinde K, Nikolic-Paterson DJ, Huang XR, Sakai H, Kurokawa K, Atkins RC, Lan HY. 2001. Tubular phenotypic change inprogressive tubulointerstitial fibrosis in human glomerulone- phritis. Am J Kidney Dis 38(4):761-769.
16. Kopydlowski KM, Salkowski CA, Cody MJ, van Rooijen N, Major J, Hamilton TA, Vogel SN. 1999. Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo. J Immunol 163(3):1537-1544.
17. Lan HY. 2003. Tubular epithelial-myofibroblast transdifferentia- tion mechanisms in proximal tubule cells. Curr Opin Nephrol Hypertens 12(l):25-29.
18. Lan HY, Mu W, Tomita N, Huang XR, Li JH, Zhu HJ, Morishita R, Johnson RJ. 2003. Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model. J Am Soc Nephrol 14(6):1535-1548.
19. Liu Y. 2004. Epithelial to mesenchymal transition in renal fibrogen- esis: pathologic significance, molecular mechanism, and thera-peutic intervention. J Am Soc Nephrol 15(1):1-12.
20. Liu Y. 2006. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 69(2):213-217.
21. Lo CM, Keese CR, Giaever I. 1993. Monitoring motion of confluent cells in tissue culture. Exp Cell Res 204(1):102-109.
22. Luyckx VA, Cairo LV, Compston CA, Phan WL, Mueller TF. 2009. Oncostatin M pathway plays a major role in the renal acute phase response. Am J Physiol Renal Physiol 296(4):F875-F883.
23. Malaval L, Liu F, Vernallis AB, Aubin JE. 2005. GP130/OSMR is the only LIF/IL-6 family receptor complex to promote osteo- blast differentiation of calvaria progenitors. J Cell Physiol 204(2):585-593.
24. Malik N, Haugen HS, Modrell B, Shoyab M, Clegg CH. 1995. Developmental abnormalities in mice transgenic for bovine oncostatin M. Mol Cell Biol 15(5):2349-2358.
25. Manotham K, Tanaka T, Matsumoto M, Ohse T, Inagi R, Miyata T, Kurokawa K, Fujita T, Ingelfinger JR, Nangaku M. 2004. Transdifferentiation of cultured tubular cells induced by hyp- oxia. Kidney Int 65(3):871-880.
26. Morikawa Y, Tamura S, Minehata K, Donovan PJ, Miyajima A, Senba E. 2004. Essential function of oncostatin m in nociceptive neurons of dorsal root ganglia. J Neurosci 24(8):1941-1947.
27. Nadasdy T, Laszik Z, Blick KE, Johnson DL, Silva FG. 1994. Tubular atrophy in the end-stage kidney: a lectin and immunohisto- chemical study. Hum Pathol 25(l):22-28.
28. Ng YY, Fan JM, Mu W, Nikolic-Paterson DJ, Yang WC, Huang TP, Atkins RC, Lan HY. 1999. Glomerular epithelial-myofibroblast transdifferentiation in the evolution of glomerular crescent for-mation. Nephrol Dial Transplant 14(12):2860-2872.
29. Ng YY, Huang TP, Yang WC, Chen ZP, Yang AH, Mu W, Nikolic-Paterson DJ, Atkins RC, Lan HY. 1998. Tubular epi- thelial-myofibroblast transdifferentiation in progressive tubu- lointerstitial fibrosis in5/6nephrectomizedrats. Kidney Int 54(3): 864-876.
30. Nightingale J, Patel S, Suzuki N, Buxton R, Takagi KI, Suzuki J, Sumi Y, Imaizumi A, Mason RM, Zhang Z. 2004. Oncostatin M, a cytokine released by activated mononuclear cells, induces epithelial cell-myofibroblast transdifferentiation via Jak/Stat pathway activation. J Am Soc Nephrol 15(l):21-32.
31. Okada H, Danoff TM, Kalluri R, Neilson EG. 1997. Early role of Fsp1 in epithelial-mesenchymal transformation. Am J Physiol 273(4 Pt 2):F563-F574.
32. Okaya A, Kitanaka J, Kitanaka N, Satake M, Kim Y, Terada K, Sugiyama T, Takemura M, Fujimoto J, Terada N, Miyajima A, Tsujimura T. 2005. Oncostatin M inhibits proliferation of rat oval cells, OC15-5, inducing differentiation into hepatocytes. Am J Pathol 166(3):709-719.
33. Papayianni A. 1996. Cytokines, growth factors, and other inflamma-tory mediators in glomerulonephritis. Ren Fail 18(5):725-740.
34. Qi W, Chen X, Poronnik P, Pollock CA. 2006. The renal cortical fi-broblast in renal tubulointerstitial fibrosis. Int J Biochem Cell Biol 38(l):1-5.
35. Rastaldi MP, Ferrario F, Giardino L, Dell'Antonio G, Grillo C, Grillo P, Strutz F, Miiller GA, Colasanti G, D'Amico G. 2002. Epithelial- mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int 62(1):137-146.
36. Sato M, Yasuteru M, Saika S, Roberts AB, Ooshima A. 2003. Targeted disruption of TGF-1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Inv 112:1486-1494.
37. Scaffidi AK, Mutsaers SE, Moodley YP, McAnulty RJ, Laurent GJ, Thompson PJ, Knight DA. 2002. Oncostatin M stimulates prolif-eration, induces collagen production and inhibits apoptosis of human lung fibroblasts. Br J Pharmacol 136(5):793-801.
38. Schena FP, Gesualdo L, Grandaliano G, Montinaro V. 1997. Progression of renal damage in human glomerulonephriti- des: is there sleight of hand in winning the game? Kidney Int 52(6):1439-1457.
39. Stahl PJ, Felsen D. 2001. Transforming growth factor-beta, base-ment membrane, and epithelial-mesenchymal transdifferen- tiation: implications for fibrosis in kidney disease! Am J Pathol 159(4):1187-1192.
40. Strutz F, Miiller GA. 2000. Transdifferentiation comes of age. Nephrol Dial Transplant 15(11):1729-1731.
41. Tanaka M, Miyajima A. 2003. Oncostatin M, a multifunctional cyto-kine. Rev Physiol Biochem Pharmacol 149:39-52.
42. Thiery JP, Sleeman JP. 2006. Complex networks orchestrate epi- thelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7(2): 131-142.
43. Vielhauer V, Anders HJ, Mack M, Cihak J, Strutz F, Stangassinger M, Luckow B, Grone HJ, Schlondorff D. 2001. Obstructive nephropathy in the mouse: progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2- and 5-positive leukocytes. J Am Soc Nephrol 12(6):1173-1187.
44. Yang J, Dai C, Liu Y. 2002. Hepatocyte growth factor gene therapy and angiotensin II blockade synergistically attenuate renal in-terstitial fibrosis in mice. J Am Soc Nephrol 13(10):2464-2477.
45. Yang J, Liu Y. 2001. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 159(4):1465-1475.
46. Zarling JM, Shoyab M, Marquardt H, Hanson MB, Lioubin MN, Todaro GJ. 1986. Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells. Proc Natl Acad Sci USA 83(24):9739-9743.
47. Zeisberg M, Strutz F, Miiller GA, Kalluri R. 1999. Epithelial- mesenchymal transdifferentiation (EMT) in renal fibrogenesis: disruption of type IV collagen with soluble NCa1 domains induces EMT. Kidney Blood Pres Res 22:255-256.